Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
BSEM · NASDAQ · Biological Products, (No Diagnostic Substances) · No 10-K yet
$0.6351−0.0724 (−10.23%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Biostem Technologies (BSEM) · oqro.io/stocks/BSEM · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Insider trade · Traded Nov 17, 2026 · Filed Nov 19, 2026
CEO sold ~$14K of BSEM shares in the open marketSource5%+ stake · Stake as of Sep 30, 2026 · Filed Nov 10, 2026
Jason Matuszewski now owns 17.4% of BSEM as a passive investorSource5%+ stake · Stake as of Sep 30, 2026 · Filed Nov 10, 2026
Andrew Van Vurst now owns 18.4% of BSEM as a passive investorSource5%+ stake · Stake as of Oct 31, 2026 · Filed Nov 5, 2026
The PNC Financial Services Group, Inc. now owns 10.4% of BSEM as a passive investorSource